The core insight
1RCH doesn't have an access problem — it has a retention problem
23
candidate service lines evaluated (20 enter/deepen + 3 excluded)
10
land in Horizon 1 (0–2 yrs) — sequenced, not simultaneous
~2,500–3,100
recapturable community-acuity discharges (est, re-underwritten)
3
structurally-locked tiers to concede by partnership, not chase
The whole strategy in one line
RCH wins the front door (~57–59% home-ZIP ED share on 61,472 visits) but keeps only 36.8% of its core inpatient market. The leak splits cleanly: a structurally-locked tier (Level I trauma, complex peds, quaternary, Kaiser closed-network — ~⅔ to 70% of the leak) RCH should not chase, and a community-acuity tier (~2,500–3,100 recapturable discharges) the right service lines can win back. The gap isn't geography — these patients are already in RCH's ED — it's service-line depth, on-call coverage, and the credibility to keep them.
Phase 0 gates everything
No service line launches — and no physician term sheet is signed — until the quality-credibility fix is underway: remediate stroke 30-day mortality (18.5, "Worse than national"), re-enter Leapfrog, and reconcile the live 2-star vs. marketed 4-star claim. The Stroke Center below is the clinical predicate for the stroke-mortality fix — quality repair and a new service line in one move.
Horizon 1 · 0–2 years
2The H1 shortlist — stop the leak
Ranked by weighted score (0–100). Sequence within H1 under the concurrent-initiative cap — a money-losing, sub-scale hospital cannot stand up all ten at once. The one capital-heavy line (cath lab) is the deliberate front-loaded exception.
| # | Service line | Score | Partner / group | Why it's H1 |
|---|---|---|---|---|
| 1 | Ortho/spine Center of Excellence + total-joint + ortho ASC | 91 | Arrowhead Orthopaedics (27+ surgeons) | Monetizes the #1 VRIO franchise (US News High Performing ×4); ASC serves daytime workers & any payer; lowest execution risk |
| 2 | Primary Stroke Center + neuro | 86 | LLUMC Adult (thrombectomy backstop) | Fixes a live quality liability and stops EMS routing strokes to LLU — quality fix + recapture in one |
| 3 | Urgent care / convenient-access front door | 86 | CIN / RYMG urgent care | Owns the front door in RCH's own city; fills Optum's 2024 retreat; feeds CIN attribution; cheap & fast |
| 4 | Observation / clinical-decision unit | 85 | Internal (on the ED moat) | Pure ED-moat conversion; near-zero capex at 56.6% occupancy; the cheapest retention lever |
| 5 | Occupational health + employer near-/on-site clinics | 85 | Direct-to-employer (ESRI, RUSD, Amazon DCs) | Monetizes the ~33,000 daytime in-commuters; payer-agnostic B2B; banks commercial lives with zero licensure |
| 6 | GI / endoscopy + ASC | 84 | Inland Gastroenterology + Endoscopy Ctr | Margin-positive outpatient; recaptures volume leaking to freestanding ASCs; colorectal-screening demand |
| 7 | Endocrinology / diabetes & cardiometabolic prevention | 83 | CIN PCPs + independent endo; payer VBC | Bullseye for the prevention vision & IE burden; whitespace; the engine of CIN value-based savings |
| 8 | General surgery / urology / ENT / bariatrics via ASC | 81 | Independent surgical specialists via CIN | Rides the outpatient surgery-mix shift; bariatrics maps to 36.5% obesity; daytime + payer-agnostic |
| 9 | Interventional cardiology (cath lab) + Chest-Pain/STEMI | 78 | On-campus Cardiovascular Specialists; Kaiser/LLU CABG backup | The capital-heavy exception — biggest case-mix lift & cardiac recapture; on-campus group de-risks staffing |
| 10 | Advanced imaging + interventional radiology | 75 | Owned/JV vs. RadNet; on-campus specialists | Enabling infrastructure for the stroke & cardiac lines; outpatient imaging serves daytime workers |
How the H1 set fits together
3Four logical groupings
1 · Quality-and-recapture quartet
Stroke Center · cath lab/STEMI · observation unit · ortho/spine COE. Three directly recapture community-acuity inpatient leak; the Stroke Center also remediates RCH's worst public quality metric. These most directly serve the "reclaim the leaked market" mandate.
2 · Ambulatory / ASC margin stack
Ortho/spine · GI/endoscopy · general-surgery/uro/ENT/bariatric · imaging. Monetizes the documented surgery-mix shift (outpatient 3,871 > inpatient 2,854) at a lower cost basis — and captures the daytime in-commuter workforce and any payer's COE referrals.
3 · Prevention / access layer
Endocrinology/cardiometabolic · occupational health · urgent care. Capital-light, whitespace-rich, and the feeder that banks resident lives (longitudinal) and daytime-worker lives (episodic) into the CIN. The forward-integration spine.
4 · H2 depth + after-service
Wound/HBO, geriatrics/palliative, hospital-at-home, pulmonology/sleep, vascular, pain, oncology deepening, behavioral health, women's-health decision, nephrology — gated by the CIN rails, heavier capital, or the concurrent-initiative cap.
Resident vs. daytime-worker segmentation runs through it
The daytime-worker lines (ortho/spine & GI & general-surgery ASCs, imaging, occ-health, urgent care, COE referrals) are payer-agnostic and sized on the ~39,000-job daytime base. The resident lines (Stroke Center, cardiac, observation/medical admissions, cardiometabolic prevention) are longitudinal and sized on residence — owning the sticky bedroom-community lives. See the segmentation →
The phased roadmap
4Reclaim-and-grow sequence
Phase 0 · mo 0–6
Quality gate
Stroke-mortality remediation · re-enter Leapfrog · reconcile the star-rating claim. Stop/go before any line or term sheet.
H1 · 0–2 yr
Stop the leak
The 10 lines above: ED-retention chain, the ASC stack, the prevention/access layer. Cheapest, highest-recapture first.
H2 · 2–5 yr
Build depth + after-service
Vascular, wound/HBO, pulmonology/sleep, pain, oncology deepening, geriatrics/palliative, hospital-at-home, behavioral health, women's-health call.
H3 · 5–10 yr
Own the model
Comprehensive Stroke / thrombectomy, owned radiation oncology, provider-sponsored plan, Pass-corridor build — each an earned option, not a commitment.
H2 deepening & after-service layer (2–5 yrs)
| Line | Score | How it defends independence |
|---|---|---|
| Vascular surgery | 74 | Recaptures community vascular leaking to LLU; synergy with cardiac/IR/wound + the diabetes-PAD burden |
| Wound care + hyperbarics | 76 | Maps to diabetes (diabetic-foot ulcers); recurring-visit, favorable reimbursement; vendor-managed lowers risk |
| Pulmonology / sleep | 74 | IE air quality + COPD; outpatient sleep scalable & daytime-friendly |
| Pain management | 73 | Deepens the spine moat; interventional pain is ASC-based |
| Oncology (deepen med-onc/infusion; rad-onc via JV) | 70 | Builds on accredited CoC; infusion commercial-rich; linac is JV/defer; quaternary stays at LLU |
| Geriatrics / palliative | 77 | Aging corridor + MA/ACO panels; palliative lowers total cost — monetized in shared-savings (needs CIN rails) |
| Hospital-at-home + post-acute | 77 | The after-service layer the value chain lacks; targets the high-cost 5% (~50% of spend); avoids bed/seismic capex |
| Behavioral health (SUD/MAT + crisis + geri-psych) | 66 | Builds on the SUD honor roll; owns outpatient/crisis whitespace; affiliates LLU's inpatient psych rather than competing it |
| Women's health (defend/grow) | 68 | Execute the defend-or-harvest OB call (births −38%); grow gyn/urogyn/breast (outpatient, commercial-rich) either way |
| Nephrology / CKD-in-CIN | 66 | Inpatient nephrology + CKD prevention in the CIN; concede chronic dialysis chairs to DaVita/Fresenius |
The discipline
5What RCH should not build
Conceding the unwinnable acuity tiers is not weakness — it's what makes focused differentiation financeable. Every dollar not spent chasing a Level I designation funds the Stroke Center, the cath lab, the ASC, and the CIN that actually keep RCH independent.
| Do NOT build | Score | Why | The partnership answer |
|---|---|---|---|
| Level I/II Trauma center | 34 | ACS-COT verification + 24/7 on-call is a fixed-cost loser at 211 beds; LLU & Arrowhead run at 109% / 86% | LLUMC + Arrowhead absorb trauma; RCH stabilizes & transfers |
| Complex pediatrics / peds tertiary | 34 | LLU Children's (364 beds) is the region's only children's hospital — an unwinnable monopoly | LLU Children's receives peds-tertiary; RCH does basic peds ED stabilization + transfer |
| Transplant / quaternary (complex CV surgery, complex onc) | 27 | Quaternary/academic care is LLUMC's franchise; no volume, capital, or staffing case | LLUMC is the quaternary referral center; RCH keeps the community-acuity follow-up |
| Owning chronic outpatient dialysis chairs | — | DaVita/Fresenius dominate; near-zero whitespace, capital-intensive commodity | Concede chairs; keep inpatient nephrology + CKD prevention in the CIN |
The two acute partnerships
LLUMC Adult (trauma / peds-tertiary / quaternary / thrombectomy / CABG-backstop) and Kaiser Fontana & Moreno Valley (closed-network crossover + capacity overflow) let RCH concede the unwinnable tiers cleanly — so its capital and management bandwidth go entirely into the recapturable community-acuity lines.
Where the volume comes back
6Top 3 leakage-recapture opportunities
- The ED-to-inpatient retention chain (observation unit + cardiac cath/STEMI + Stroke Center). RCH already has the patient at ~57–59% ED share but admits only ~37% of the area's inpatient cases. Building the depth to keep community-acuity admissions — chest pain/NSTEMI, ischemic stroke, CHF/pneumonia/COPD/sepsis — is the largest recapturable pool, with near-zero new market access.
- Elective surgery leaking to freestanding ASCs (ortho/spine + GI + general/uro/ENT). Three ASCs sit within blocks of campus; the surgery mix already tilted outpatient (3,871 > 2,854). An owned/co-owned ASC on the ortho franchise recaptures this margin and serves the daytime workforce.
- Cardiac volume routing to LLU for want of an interventional program. With no cath lab/PCI/STEMI designation, community cardiac defaults to LLU. A cath lab + Chest-Pain Center, staffed by the on-campus cardiology group, recaptures it and lifts case-mix.
How the whole program defends independence
A hospital that has recaptured its leak, owns its front door, anchors a physician network the giants cannot, and manages the region's chronic disease at risk is not a distressed-sale candidate. H1 flips the operating line on assets RCH already owns; the ASC + prevention lines deepen the moat and feed the CIN; H2 builds the value-based margin engine; H3 keeps the option to own the full premium dollar — earned, not assumed. That is the entire point of the sequence.
← Strategy Analysis · Competitor Map & overlays · Pro Forma · Growth →
Method & honest flags. 23 candidate lines scored 1–5 on eight weighted criteria (leakage-recapture 18% and market need 16% weighted highest); weighted score on a 0–100 scale; tier is a separate sequencing judgment (a few high-70s lines sit in H2 because they need the CIN rails first, and advanced imaging sits in H1 as enabling infrastructure). Key data limitation: the HCAI patient-origin file has no DRG/service-line detail — the restricted HCAI Patient Discharge Data (PDD) would let the team compute leakage by DRG family and convert the ~⅔–70% tertiary-split assumption into a measured number. The ~2,500–3,100 recapturable figure is the adversarially re-underwritten estimate from the Strategy Analysis; the board case should anchor at a 40–42% core-share target (+480 to +788 discharges) reported in contribution margin, not gross revenue. Source-of-truth authorities: CA HCAI; CMS Care Compare/PDC; CA Title 22 CCR & H&S §1250 (licensure); B&P §2400 (CPOM); H&S §1340 (Knox-Keene); AB1415/OHCA; TJC/DNV (stroke & cardiac certification); ACC (Chest Pain Center); ACS-COT (trauma); ACS Commission on Cancer. Full detail in service_line_market_entry.md and service_line_scorecard.csv. Planning analysis — not clinical, legal, actuarial, or investment advice.